Festal NEO (pancreatin) 10000 enteric tablets №20

$12.00

Manufacturer: Ukraine

Diseases that are accompanied by violations of the process of digestion of food due to insufficient allocation of digestive enzymes by the pancreas, such as chronic pancreatitis. Conditions after simultaneous resection of the stomach and small intestine, conditions after pancreatectomy. Functional acceleration of food passage through the intestines. Flatulence, indigestion, disorders of the intestine. Preparation for x-ray or ultrasound diagnostic tests of abdominal organs (intestinal degassing). To improve the digestion of food for people with normal gastrointestinal function in the case of violations of the rational diet (heaviness in the stomach, eating a large amount of food, eating fatty, fried or unusual food, eating vazhkoperetravlyuvanoyi plant food, irregular nutrition), with violations of chewing function.

Category:

Description

Composition active substance Festal Neo:

pancreatin; 1 tablet contains pancreatin, which corresponds to the minimum enzymatic activity: 10,000 lipolytic MO, 7,500 amylolytic MOs, 375 proteolytic IUs Festal Neo excipients: lactose, microcrystalline cellulose, croscarmellose sodium, crospovidone, hypromellose, colloidal silicon dioxide: polyethylene stearate shell , dry mix “Acryl-eze white” containing talc, titanium dioxide (E 171), methacrylate copolymer, sodium lauryl sulfate, sodium carbonate, colloidal silicon dioxide.

DOSAGE FORM

Film-coated tablets.

MAIN PHYSICO-CHEMICAL PROPERTIES:

Festal Neo – tablets, film-coated, round, beveled, white or almost white, with a weak specific odor. The cross section shows two layers.

PHARMACOLOGICAL GROUP

Digestive aids, including enzymes. Polyenzyme preparations. ATX code A09A A02.

PHARMACOLOGICAL PROPERTIES

Pharmacological. Pancreatin is a pancreatic enzyme that aids in digestion. The drug contains the main pancreatic enzymes: lipase, α-amylase, proteases (trypsin and chymotrypsin), which have lipolytic, amylolytic and proteolytic effects, enhance the breakdown of proteins, carbohydrates and fats in the duodenum, the proximal part of the small intestine, contributes to their more complete absorption. The decisive factor is the enzymatic activity of the lipase as well as the trypsin content. Pharmacokinetics. The shell covering the Festal Neo tablets is insoluble under the action of gastric juice and protects enzymes from their inactivation by gastric juice. Only under the action of the neutral or slightly alkaline medium of the small intestine does the Festal Neo membrane dissolve and the release of enzymes. Indications Diseases accompanied by impaired digestion of food due to insufficient secretion of digestive enzymes by the pancreas, such as chronic pancreatitis. Conditions after simultaneous resection of the stomach and small intestine, conditions after pancreatectomy. Functional acceleration of the passage of food through the intestines. Flatulence, dyspepsia, bowel disorders. Preparation for X-ray or ultrasound diagnostic examinations of the abdominal organs (intestinal degassing). To improve the digestion of food for persons with normal function of the gastrointestinal tract in case of violations of the diet (heaviness in the stomach, eating large amounts of food, eating fatty, fried or unusual food, eating hard-to-digest plant foods, irregular nutrition), in case of violation of chewing function … Contraindications Hypersensitivity to porcine pancreatin or to excipients of the drug. Acute pancreatitis or chronic pancreatitis in the acute stage. Festal Neo should not be used in patients with obstructive intestinal obstruction.

SPECIAL SAFETY MEASURES

Festal Neo contains active enzymes that can damage the mucous membrane of the oral cavity, up to the formation of ulcers, so the tablets must be swallowed whole without chewing. Festal Neo should not be used in patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose and galactose malabsorption syndrome. Use Festal Neo with caution in patients with renal insufficiency, hyperurinemia, patients with allergy to porcine proteins.